CompletedPhase 2NCT01359969
Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Studying Hereditary angioedema
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Pharming Technologies B.V.
- Principal Investigator
- Anurag Relan, MDVP Clinical Research & Medical Affairs at Pharming
- Intervention
- rhC1INH(drug)
- Enrollment
- 57 enrolled
- Eligibility
- 2-13 years · All sexes
- Timeline
- 2012 – 2017
Study locations (16)
- Portland Clinical Research/AAIM Care, LLC, Portland, Oregon, United States
- UIA FN Plzen ( Institute of Immunology and Allergology), Faculty Hospital Plzen, Pilsen, Alej Svobody 80, Czechia
- University Hospital Motol, Institute of Immunology, Prague, V Úvalu 84, Czechia
- Charité - Universitätsmedizin Berlin, Berlin, Charitéplatz 1, Germany
- Klinikum Rechts der Isar, Technical University Munich, Munich, Germany
- Heim Pál Gyermekkórház, II. számú Gyermek Belgyógyászati Osztály, Budapest, Madarász Utca 22-24, Hungary
- Bnei Zion Hospital, Haifa, Israel
- Souraski Medical Center, Tel Aviv, Israel
- Sheba Medical Center, Tel Litwinsky, Israel
- Hospital Luigi Sacco, Milan, Italy
- Azienda Ospedaliera Universitaria S. Giovanni di Dio e Ruggi d'Aragona, Salerno, Italy
- University Clinic Of Dermatology Skopje, Skopje, North Macedonia
- Pediatric Hospital, Krakow, Poland
- Pediatric Hospital, Lublin, Poland
- Mures County Clinical Hospital, Târgu Mureş, Romania
- +1 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01359969 on ClinicalTrials.govOther trials for Hereditary angioedema
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07298447Donidalorsen Treatment in Children With Hereditary AngioedemaIonis Pharmaceuticals, Inc.
- RECRUITINGNANCT07559630Single-center Randomized Controlled Trial of Rectal Arterial Embolization vs Band Ligation for the Treatment of Internal hemOrrhoidSJessica K. Stewart, MD
- RECRUITINGPHASE3NCT07428499Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)ADARx Pharmaceuticals, Inc.
- RECRUITINGNANCT07251933A Study of Lanadelumab in Children With Hereditary Angioedema (HAE) in Multiple CountriesTakeda
- ENROLLING BY INVITATIONPHASE3NCT07204938A Long-Term Study of Navenibart in Participants With Hereditary AngioedemaAstria Therapeutics, Inc.
- RECRUITINGPHASE3NCT06960213STOP-HAE: A Phase 3 Study of ADX-324 in HAEADARx Pharmaceuticals, Inc.
- RECRUITINGNANCT07001280A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)CSL Behring
- RECRUITINGPHASE3NCT06842823A Study of Navenibart in Participants With Hereditary AngioedemaAstria Therapeutics, Inc.